Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-11-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1073/pnas.0806669105PMID 19004793PMCID PMC2584724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia

  2009cited by this paper
• Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia

  2008cited by this paper
• DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia.

  2008cited by this paper
• Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia

  2008cited by this paper
• Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

  2008cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007influential reference
• Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology.

  2007cited by this paper
• Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders.

  2007cited by this paper
• Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.

  2007cited by this paper
• Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine

  2007influential reference
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• Orbitofrontal volume deficit in schizophrenia and thought disorder.

  2007cited by this paper
• Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans

  2007cited by this paper
• Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.

  2007influential reference
• Prefrontal cortex and insight in schizophrenia: a volumetric MRI study.

  2007cited by this paper
• Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction.

  2007cited by this paper
• Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction.

  2007cited by this paper
• Dysfunctional prefrontal regional specialization and compensation in schizophrenia.

  2006cited by this paper
• A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions.

  2006cited by this paper
• Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.

  2006cited by this paper
• Progression of Cellular Adaptations in Medial Prefrontal and Orbitofrontal Cortex in Response to Repeated Amphetamine

  2006influential reference
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Cortical inhibitory neurons and schizophrenia

  2005influential reference
• Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.

  2005cited by this paper
• Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities.

  2005cited by this paper
• Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.

  2005cited by this paper
• Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study.

  2005cited by this paper
• A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse.

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia.

  2004cited by this paper
• Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.

  2004cited by this paper
• Physiological Roles and Therapeutic Potential of Metabotropic Glutamate Receptors

  2003cited by this paper
• Encoding predicted outcome and acquired value in orbitofrontal cortex during cue sampling depends upon input from basolateral amygdala.

  2003cited by this paper
• Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

  2003cited by this paper
• Prefrontal neurons and the genetics of schizophrenia.

  2001influential reference
• The orbitofrontal cortex and reward.

  2000cited by this paper
• Emotion, decision making and the orbitofrontal cortex.

  2000cited by this paper
• Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study.

  2000cited by this paper
• Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.

  2000cited by this paper
• Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia.

  2000cited by this paper
• Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning

  1998cited by this paper
• Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.

  1997cited by this paper
• LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

  1997cited by this paper
• Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex : Focal abnormalities in orbitofrontal cortex in schizophrenia

  1997cited by this paper
• Orbitofrontal cortex neurons: role in olfactory and visual association learning.

  1996cited by this paper
• NMDA-dependent modulation of CA1 local circuit inhibition

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Institute of Laboratory Animal Resources.

  1995cited by this paper
• A functional neuroanatomy of hallucinations in schizophrenia

  1995influential reference
• Cerebral cortical mechanisms in schizophrenia

  1994cited by this paper
• Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia.

  1988cited by this paper
• The current status of the dopamine hypothesis of schizophrenia.

  1988cited by this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987influential reference
• Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid.

  1987cited by this paper
• Non-competitive regulation of phencyclidine/σ-receptors by the N-methyl-d-aspartate receptor antagonist d-(−)-2-amino-5-phosphonovaleric acid

  1987cited by this paper
• Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

  1973cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Acute ketamine withdrawal disrupts memory and monoaminergic neurotransmission in adolescent female rats.

  2026cites this paper
• Glutamate Metabotropic Receptors-Linked Postsynaptic Density Proteins: An Emergent Hub for Antipsychotics' Regulation of Synaptic Plasticity and Metaplasticity.

  2026cites this paper
• The Effects of Antipsychotic Drugs and Non-Pharmacological Therapies on Schizophrenia

  2025cites this paper
• What value do NMDA receptor antagonist models of schizophrenia have for novel drug discovery?

  2025cites this paper
• 20 Years of Aberrant Salience in Psychosis: What Have We Learned?

  2025cites this paper
• Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

  2024cites this paper
• Characterization of dopaminergic projections from the ventral tegmental area and the dorsal raphe nucleus to the orbital frontal cortex

  2023cites this paper
• Postnatal Phencyclidine-Induced Deficits in Decision Making Are Ameliorated by Optogenetic Inhibition of Ventromedial Orbitofrontal Cortical Glutamate Neurons

  2023cites this paper
• Modulation of ventromedial orbitofrontal cortical glutamatergic activity affects the explore-exploit balance and influences value-based decision-making.

  2022cites this paper
• Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia

  2022cites this paper
• Frontal lobe fALFF measured from resting-state fMRI at baseline predicts acute treatment response in first episode psychosis

  2021cites this paper
• Acute administration of typical and atypical antipsychotics reduces EEG power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in power

  2021cites this paper
• Neurocognitive disorders in the elderly: altered functional resting-state hyperconnectivities in postoperative delirium patients

  2021cites this paper
• A selective serotonin reuptake inhibitor ameliorates obsessive-compulsive disorder-like perseverative behavior by attenuating 5-HT2C receptor signaling in the orbitofrontal cortex.

  2021cites this paper
• Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia

  2020cites this paper
• NMDA receptors in visual and olfactory sensory integration in male long evans rats: a role for the orbitofrontal cortex.

  2020cites this paper
• 16p11 Duplication Disrupts Hippocampal-Orbitofrontal-Amygdala Connectivity, Revealing a Neural Circuit Endophenotype for Schizophrenia.

  2020cites this paper
• Title : Receptors , circuits and neural dynamics for prediction 1

  2020cites this paper
• Psychotic symptoms are associated with lower cortical folding in youth at risk for mental illness

  2020cites this paper
• Examination of Cognitive Deficits Produced by Sub-Chronic Ketamine Exposure in Rats

  2020cites this paper
• Predictive Feedback, Early Sensory Representations, and Fast Responses to Predicted Stimuli Depend on NMDA Receptors

  2020cites this paper
• QUANTITATIVE SUBCELLULAR PROTEOMICS OF THE ORBITOFRONTAL CORTEX OF SCHIZOPHRENIA PATIENTS.

  2019cites this paper
• Amphetamine disrupts haemodynamic correlates of prediction errors in nucleus accumbens and orbitofrontal cortex

  2019cites this paper
• VGLUT3 gates psychomotor effects induced by amphetamine

  2019cites this paper
• Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators

  2018cites this paper
• Effects of monoamines on the intrinsic excitability of lateral orbitofrontal cortex neurons in alcohol‐dependent and non‐dependent female mice

  2018cites this paper
• Variants of the Spontaneous Recognition Procedure Assessing Multisensory Integration Reveal Behavioral Alterations in Rodent Models of Psychiatric and Neurological Disorders

  2018cites this paper
• The impact of early environmental interventions on structural plasticity of the axon initial segment in neocortex

  2017cites this paper
• Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study

  2017cites this paper
• Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability

  2017cites this paper
• A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex

  2016cites this paper
• Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses.

  2016cites this paper
• Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

  2015influential citation
• Glutamatergic agents for schizophrenia: current evidence and perspectives

  2015cites this paper
• When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy.

  2015cites this paper
• α₄β₂ Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia.

  2015cites this paper
• mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task

  2014cites this paper
• mGluR5 Positive Allosteric Modulation as a Novel Therapeutic Target for the Cognitive Deficits Associated with Schizophrenia

  2014cites this paper
• Antipsychotic treatment modulates glutamate transport and NMDA receptor expression

  2014cites this paper
• Characterization of electrically evoked field potentials in the medial prefrontal cortex and orbitofrontal cortex of the rat: modulation by monoamines.

  2014cites this paper
• Gamma-band synchronization in the neocortex: novel analysis methods and their application to sensory and motivational systems

  2013cites this paper
• Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.

  2013cites this paper
• Molecular imaging as a guide for the treatment of central nervous system disorders

  2013cites this paper
• Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.

  2013cites this paper
• Disturbed function of GABAergic interneurons in schizophrenia: relevance for medical treatment?

  2012cites this paper
• Distinct prefrontal cortical regions negatively regulate evoked activity in nucleus accumbens subregions.

  2012cites this paper
• Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder

  2012cites this paper
• NMDA receptors control cue-outcome selectivity and plasticity of orbitofrontal firing patterns during associative stimulus-reward learning.

  2012cites this paper
• Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia.

  2012cites this paper
• Auditory hallucinations: expectation-perception model.

  2012cites this paper
• Stress Transiently Affects Pavlovian-to-Instrumental Transfer

  2012cites this paper
• Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs

  2012cites this paper
• Arg Kinase Regulates Prefrontal Dendritic Spine Refinement and Cocaine-Induced Plasticity

  2012cites this paper
• Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology.

  2012cites this paper
• Striatum processes reward differently in adolescents versus adults

  2012cites this paper
• Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.

  2012cites this paper
• Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

  2012cites this paper
• Metabotropic glutamate receptors for new treatments in schizophrenia.

  2012cites this paper
• The glutamate hypothesis of schizophrenia: neuroimaging and drug development.

  2012cites this paper
• Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia

  2012cites this paper
• Higher Gamma-Aminobutyric Acid Neuron Density in the White Matter of Orbital Frontal Cortex in

  2012cites this paper
• Neural Correlates of Adolescent Behavior

  2011cites this paper
• Cell adhesion signaling pathways

  2011cites this paper
• MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.

  2011cites this paper
• Molecular etiologies of schizophrenia: are we almost there yet?

  2011cites this paper
• Cell adhesion signaling pathways: First responders to cocaine exposure?

  2011cites this paper
• Projections of the medial orbital and ventral orbital cortex in the rat

  2011cites this paper
• Reduced Neuronal Inhibition and Coordination of Adolescent Prefrontal Cortex during Motivated Behavior

  2011cites this paper
• mGluR7 Genetics and Alcohol: Intersection Yields Clues for Addiction

  2011cites this paper
• Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.

  2011cites this paper
• Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain

  2011cites this paper
• Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders

  2011cites this paper
• mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration.

  2011cites this paper
• Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

  2010cites this paper
• Glutamatergic Targets for Enhancing Extinction Learning in Drug Addiction

  2010cites this paper
• Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?

  2010cites this paper
• Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia.

  2010cites this paper
• Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

  2010cites this paper
• Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition.

  2010cites this paper
• Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.

  2009cites this paper
• Differential representation of Pavlovian–instrumental transfer by prefrontal cortex subregions and striatum

  2009influential citation
• How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia.

  2009cites this paper
• Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.

  2009cites this paper
• Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3–6 February 2009

  2009cites this paper